SlideShare a Scribd company logo
www.duanemorris.com
©2011 Duane Morris LLP. All Rights Reserved. Duane Morris is a registered service mark of Duane Morris LLP.
Duane Morris – Firm and Affiliate Offices | New York | London | Singapore | Los Angeles | Chicago | Houston | Hanoi | Philadelphia | San Diego | San Francisco | Baltimore | Boston | Washington, D.C.
Las Vegas | Atlanta | Miami | Pittsburgh | Newark | Boca Raton | Wilmington | Cherry Hill | Princeton | Lake Tahoe | Ho Chi Minh City | Duane Morris LLP – A Delaware limited liability partnership
Ken Keane, Lisa Clark and Michael Swit
mHealth Converges: The Impact of FCC,
HIPAA/Privacy and FDA
An Fx Conferences Audio Conference
May 21, 2013
www.duanemorris.com
Standard Disclaimers
• Views expressed here are solely ours and
do not reflect those of our firm or any of its
clients.
• This presentation supports an oral briefing
and should not be relied upon solely on its
own to support any conclusion of law or
fact.
• This presentation, and the materials
included herewith, are provided for general
educational purposes and should not be
construed as legal advice.
2
www.duanemorris.com
What We Will Cover
• Background on mHealth – Lisa Clark
• The FCC and mHealth – Ken Keane
• FDA and mHealth – Michael Swit
• Privacy and Security/HIPAA and mHealth –
Lisa Clark
3
www.duanemorris.com
Background on mHealth
Lisa Clark
4
www.duanemorris.com
What is mHealth? Terms and
Definitions
• mHealth
– is health care delivered wirelessly
– facilitates health data exchange
– is replacing bricks-and-mortar health care delivery
• Closely related term: Health Information
Technology (HIT)
• Other terms: Telemedicine, Telehealth, Wireless
Health, eHealth, Digital Health
5
www.duanemorris.com
mHealth Devices and Platforms
• Medical devices:
– Glucose meters that transmit results to electronic
health record (EHR) or lab
– Wearable devices to track patients who may wander
• Medical apps/software
– Tablet or smart phone with app that provides general
medical information to physicians at bedside
• Other software
– Software that supports health information exchanges
(HIEs) and electronic health records (EHRs)
6
www.duanemorris.com
Who uses mHealth?
1. Consumers (for themselves)
- Weight apps
2. Consumers-Providers/Providers-Consumers
- Glucose meters
- Telepsychiatry
3. Providers-Providers
- Teleradiology
4. Payors-Providers, Payors-Consumers
7
www.duanemorris.com
The mHealth Stakeholders
1. Device makers, pharma
2. Start-ups, etc.
3. Investors
4. Payors
5. Providers
6. Consumers
7. Government
8. Others:
1. Standard setting organization, academia, telecom, private
organizations
8
www.duanemorris.com
Expected Growth in mHealth
• Anticipated growth:
– $27.3B by 2016 (BCC Research)
– Growth rate at 22% through 2014 (RNCOS)
• Simultaneous contraction in hospital-based
and other traditional healthcare services
(physician visits, etc.).
9
www.duanemorris.com
• Federal Communications Commission (FCC)
• Food & Drug Administration (FDA)
• Health and Human Services (HHS)
– Office of the National Coordinator (ONC)
– Centers for Medicare and Medicaid Services (CMS)
• Federal Trade Commission (FTC)
• Other
– Department of Homeland Security
– Department of Commerce (National Telecommunications and
Information Administration)
– States, etc.
10
Who is Regulating mHealth?
www.duanemorris.com
mHealth/Government Interest
• Government -- actively tracking mHealth and
HIT and why, where, and how to jump in.
– 62 government committees (!) looking at mHealth/HIT.
• Congress – three days of hearings in mid-
March 2013
11
www.duanemorris.com
mHealth/Government Interest …
• The Food and Drug Administration Safety
Innovation Act (FDASIA) Workgroup:
– “charged with providing expert input on issues and concepts
identified by the Food and Drug Administration (FDA), Office of the
National Coordinator for Health IT (ONC), and the Federal
Communications Commission (FCC) to in order to inform the
development of a report on an appropriate, risk-based regulatory
framework pertaining to health information technology including
mobile medical applications that promotes innovation, protects
patient safety, and avoids regulatory duplication.”
– First meeting was on April 29, 2013. Slides from meeting are at
www.healthit.gov/sites/default/files/fdasia_kickoff_faca_slides.pdf
12
www.duanemorris.com
mHealth/This Presentation
• We will review key mHealth activities regarding
– FCC
– FDA
– Privacy and security/HIPAA
• Other areas of interest include (not discussed today)
– Reimbursement (Medicare, Medicaid and private)
– Fraud and abuse
– Licensure
– Liability/insurance/malpractice
– IP
13
www.duanemorris.com
The FCC and mHealth
Ken Keane
14
www.duanemorris.com
FCC -- History in Wireless Medical
Technology
• Allocated spectrum for low-power medical
telemetry 40 years ago
• 460-470 MHz
• Unlicensed medical applications also long allowed
under FCC Rules
• In 1999, established rules for implanted
devices like wireless defibrillators (aka
Medical Implant Communications Service or
“MICS”)
• 402-405 MHz15
www.duanemorris.com
FCC – History with Wireless Medical …
• In 2000, designated 14 MHz for Wireless
Medical Telemetry
• 608-614 MHz and 1.4 GHz range
• Used for telemetering patient monitoring data to
central stations
• In 2009, established Medical Device
Radiocommunication Service (“MedRadio”)
• Incorporated MICS and expanded allocation to include
401-406 MHz
• Expanded rule to accommodate body-worn devices.
• Rules harmonized with those in other Regions of the
world16
www.duanemorris.com
FCC – History with Wireless Medical …
• Applications include e.g. blood glucose monitors, and
body-worn devices
• In 2010, FCC signed Memorandum of Understanding
with FDA. Intended to increase efficiency of
regulatory processes for wireless medical devices
by, e.g.
• Enhancing information sharing
• Coordinating approval processes
17
www.duanemorris.com
FCC – History with Wireless Medical …
• In 2011, rules adopted for Medical
Micropower Networks
• Implanted devices surgically injected to provide
artificial nervous system for stroke victims, wounded
soldiers, and others with traumatic brain injuries
• Spectrum allocated in response to Petition by Alfred
Mann Foundation
• 24 MHz in four six megahertz blocks in UHF band
18
www.duanemorris.com
MBAN Devices -- Background
• In 2012, adopted rules for Medical Body
Area Network Systems (“MBAN”)
• Wireless devices for a wide variety of functions such as
blood pressure monitoring, delivery of electrocardiogram
readings, and neonatal monitoring
• MBAN devices designed to be deployed widely within a
hospital setting and make use of inexpensive, disposable
(band-aid sized) body-worn sensors/transmitters
• MBAN technology to facilitate movement of patients to
different parts of the health care facility for treatment, and
reduce risk of infection from wired sensors
19
www.duanemorris.com
• limitations of physical cables keep nearly half of all
patients from being actively monitored. MBANs allow
for ubiquitous and reliable monitoring, and give health
care providers the chance to identify life-threatening
problems or events before they occur
• According to Institute for Healthcare Improvement, a
monitored hospital patient has a 48% chance of
surviving a cardiac arrest -- number drops to 6% without
monitoring
20
MBAN Devices -- Background (con’t)
www.duanemorris.com
MBAN Rules
• MBAN decision allocated 40 MHz of spectrum at
2360-2400 MHz for MBAN use on a secondary basis
• Expansion of existing MedRadio Service in Part 95 of Rules
• Permits MBAN devices to operate on a ‘license-by-rule’ basis in
which users will not have to apply for and receive individual
station licenses
• Expected to lead to rapid and widespread development of
innovative MBAN applications
21
www.duanemorris.com
MBAN Rules (con’t)
• MBAN to share spectrum with primary aviation
users, industry and Government. Rules contain
registration and coordination provisions to protect
flight test telemetry operations conducted by
aerospace companies and government users.
• 2360-2390 MHz long used exclusively for flight test telemetry
between aircraft under test and engineers on the ground
• Enables engineers to monitor performance of aircraft in real-
time, and warn pilot in the event of any anomalous condition is
detected
• Utilizes large, dish-type tracking antennas which are very
sensitive to interference
22
www.duanemorris.com23
www.duanemorris.com
MBAN Rules (con’t)
• While registration with a medical coordinator will be
required, vast majority of MBAN systems in 2360-
2390 MHz will not require coordination with flight
test operations due to geographic separation
• Use of 2360-2390 MHz restricted to indoor operation
at health care facilities at 1 mW
• MBAN devices in the 2390-2400 MHz band will also
share spectrum, but will not require coordination,
and may be used in any location -- including in
residential settings and ambulances -- and at higher
power (20 mW). However, 10 MHz likely not
sufficient in hospital settings.
24
www.duanemorris.com
Registration/Coordination Process:
• Hospital will register with an “MBANs coordinator.”
• MBANs coordinator analyzes proposal and provides
data on proposed deployment to aerospace
coordinator
• In the great majority of cases, there will not be any
interference risk, and coordination not necessary
• In cases where analysis shows a risk of
interference, aerospace and medical coordinators
will seek to resolve situation so as to facilitate
successful deployment without risk of interference
to flight testing
25
www.duanemorris.com
Registration/Coordination Process
(con’t)
• Upon successful coordination, medical coordinator
will issue hospital an “electronic key” allowing
activation of MBAN systems
• Beacons in hospitals ensure MBAN systems do not
operate out-of-doors in 2360-2390 MHz band
• In the unlikely event of interference to flight test
telemetry, MBANs must immediately shut down
26
www.duanemorris.com
Registration/Coordination Process
(con’t)
• As part of the registration process for operating
MBAN devices in the 2360-2390 MHz band, hospital
will provide medical coordinator with a point of
contact responsible for making changes to MBAN
operating parameters (such as discontinuing
operations or changing frequencies)
• Most MBAN systems expected to be capable of
defaulting to 2390-2400 MHz band
• FCC expects its licensees to work together to
resolve any instances of harmful interference
27
www.duanemorris.com
Current MBAN Status
• When FCC issued decision, certain issues identified
for further comment. Those issues included, in
particular, selection of a medical coordinator or
coordinators for MBANs.
• Aerospace industry coordinator already designated,
i.e. AFTRCC (association of aerospace companies)*
___________________________
* Duane Morris is counsel for AFTRCC.
28
www.duanemorris.com
Current MBAN Status (con’t)
• AFTRCC, GE Healthcare, and Philips Healthcare
have filed Joint Petition for Reconsideration
regarding issues where the Commission departed
from the proposed rules that the parties had
negotiated and presented
• Petition proposes a number of changes to more closely align
FCC rules with IEEE standards
• One issue is eligibility for 2360-2390 MHz, i.e. Commission’s
decision to allow all clinics, no matter how small, to utilize
MBANs devices in this band
29
www.duanemorris.com
Current MBAN Status (con’t)
• Petitioners have urged that MBAN systems be limited to
hospitals and other health care facilities which offer patient
beds on a 24-hour basis. Small clinics, which do not need 30
MHz, could use 2390-2400 MHz
• Decision probable by year end
30
www.duanemorris.com
Other FCC Activity
• June 2012, FCC established mHealth Task Force
• September 2012, Task Force issued Report
• FCC Chairman Genachowski announced steps that
FCC will take to implement key recommendations in
Task Force Report including:
• Streamlining experimental licensing rules to permit easier
testing of mHealth devices
• Reform of Rural Health Care Program to facilitate broadband
connections, especially in rural areas (decision issued in
December)
31
www.duanemorris.com
Other FCC Activity (con’t)
• Directed FCC’s International Bureau to work with regulators in
other countries to encourage making spectrum available for
MBANs and to discuss spectrum harmonization
• Determined to hire Health Care Director who would act as
POC on all health-related issues (now on board)
* * *
32
www.duanemorris.com
FDA and MHealth
Michael Swit
33
www.duanemorris.com
What is a Medical Device?
• “Device” – Section 201(h) of the Federal Food,
Drug, and Cosmetic Act (the Act): means:
– an instrument, apparatus, implement, machine, contrivance,
implant, in vitro reagent, or other similar or related article,
including any component, part, or accessory, which is—
 recognized in the official National Formulary, or the United States
Pharmacopeia, or any supplement to them,
 intended for use in the diagnosis of disease or other conditions, or in the cure,
mitigation, treatment, or prevention of disease, in man or other animals, or
 intended to affect the structure or any function of the body of man or other
animals, and
which does not achieve its primary intended purposes through chemical
action within or on the body of man or other animals and which is not
dependent upon being metabolized for the achievement of its primary
intended purposes.
34
www.duanemorris.com
Is Software a Medical Device?
• Yes, if it fits the definition of Section 201(h),
where the main focus will be how the software
can be used to treat, prevent or diagnose
disease
35
www.duanemorris.com
FDA – Basics of Device Regulation
• Devices are classified per risk – 3 Classes
– Class I – least risky; typically do not require prior FDA
review or approval, but must meet all other “general
controls” applicable to all medical devices (e.g., facility
registration, device listing, MDR reports)
– Class II – more risky – typically require FDA clearance
of a “Premarket Notification” Submission or “510(k)”
 Standard for clearance of 510(k) – “substantial
equivalence” to an already lawfully marketed device
36
www.duanemorris.com
FDA – Basics of Device Regulation
– Class III – most risky – require approval of a
Premarket Approval Application (PMA) –
 Standard of approval – reasonable assurance of safety
and effectiveness, based on clinical investigations
• Classification – required of all devices on market
as of May 1976; over 1,000 devices classified as
to:
– Identification – i.e., what is the device?
– Intended use
– Technological characteristics
37
www.duanemorris.com
Key to FDA Device Marketing
• Must find a classification that your device
meets
– If not, and your device is new technology, by operation
of law, your device is automatically placed in Class III
• Device “classification” and mHealth Devices –
– Is your product a device at all?
 Even if it is, if the use is so “minor,” will FDA allow me to
come to market easily?
 If it is, finding a device classification that your mHealth
device meets
– If you can’t, what do you do about being automatically
placed in Class III?38
www.duanemorris.com
FDA’s Draft Guidance on Mobile
Medical Applications
• July 2011 – in reply to concerns about FDA
regulation of mobile apps, agency issues draft
guidance
– http://www.fda.gov/downloads/MedicalDevices/DeviceRegulationandGuidance/Gui
danceDocuments/UCM263366.pdf
– “mobile app" -- defined as a software application that
can be executed (run) on a mobile platform, or a web-
based software application that is tailored to a mobile
platform, but is executed on a server.
39
www.duanemorris.com
FDA’s Draft Guidance on Mobile
Medical Applications …
– “mobile medical application” (MMA) -- mobile app that
meets the definition of "device" in section 201(h) of the
Federal Food, Drug, and Cosmetic Act (FD&C Act) and
either:
 is used as an accessory to a regulated medical device;
or
 transforms a mobile platform into a regulated medical
device.
– Intended use – is key to determining if it is a medical
device; can be inferred by FDA from many sources
– Others – FDA will not enforce at this time
40
www.duanemorris.com
Draft Guidance – NOT an MMA
• Electronic copies of textbooks, teaching aids, or
reference materials
• General health & wellness apps -- solely used to
log, record, track, evaluate, or make decisions or
suggestions related to developing or maintaining
general health and wellness
– e.g. – dietary tracking logs; appointment reminders;
dietary suggestions based on calorie counting
• Automated office functions – e.g., billing,
inventory
41
www.duanemorris.com
Draft Guidance – NOT an MMA …
• Generic aids -- that assist users but are not
commercially marketed for a specific medical
indication.
– e.g., apps that use the mobile platform as a magnifying
glass (but not specifically for medical purposes),
recording audio, note-taking, replaying audio with
amplification, and other similar functionalities.
• Mobile apps that perform the functionality of an
electronic health record system or personal
health record system.
42
www.duanemorris.com
Draft Guidance – Apps FDA Will
Regulate
• Apps that are an extension of one or more
medical device(s) by connecting to such
device(s) for purposes of controlling the device(s)
or displaying, storing, analyzing, or transmitting
patient-specific medical device data.
– Examples – are considered “accessories”
 remote display of data from bedside monitors
 display of medical images
 remote control of drug delivery of an infusion pump
– Take on classification of device to which connected
43
www.duanemorris.com
Draft Guidance – Apps FDA Will
Regulate …
• Apps that transform the mobile platform into a
medical device by using attachments, display
screens, or sensors or by including functionalities
similar to those of currently regulated medical
devices.
– Example: AliveCor™ iPhone based ECG system –
physical attachment to an iPhone that converts it into
an ECG and transmits data via web
 510(k) cleared in November 2012
44
www.duanemorris.com
Draft Guidance – Apps FDA Will
Regulate …
• Apps that allow the user to input patient-specific
information and - using formulae or processing
algorithms - output a patient-specific result,
diagnosis, or treatment recommendation to be
used in clinical practice or to assist in making
clinical decisions.
45
www.duanemorris.com
Why mHealth and FDA Don’t “Connect”
• Lack of Transparency –
– While FDA says it has reviewed and cleared/approved
over 75 mHealth devices, not clear what FDA required
as 2011 draft guidance is “generic” in nature
 no specific guidances for clearances
 difficult to find detailed info on “per device” requirements
• Many mHealth Devices do not fit existing
device classifications
– Result – automatic Class III status under law
 Challenge – de novo petition process is unwieldy
46
www.duanemorris.com
Why mHealth and FDA Don’t “Connect”
• Need for more guidance
– 2011 Guidance – said more guidance would be
provided to cover:
 Apps that use data from more than one kind of medical
device
 Clinical decision support software
 Wireless safety considerations – for example, rumor that
at least one FDAer involved in mHealth issues would
require that developers prove their apps not interfere
with other devices used in healthcare settings
 Application of Quality System Regulation (QSR) to
software
47
www.duanemorris.com
The AliveCor™ Device & App
48
www.duanemorris.com49
www.duanemorris.com
How it Came to Market
• Classification – 21 CFR 870.2340
Electrocardiograph.
– (a) Identification. An electrocardiograph is a device
used to process the electrical signal transmitted
through two or more electrocardiograph electrodes and
to produce a visual display of the electrical signal
produced by the heart.
– (b) Classification. Class II (performance standards).
• Seven consensus standards and an FDA
guidance document apply – check “Product
Code” to figure that out – “DPS”
http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpcd/classification.cfm?ID=666
50
www.duanemorris.com
So, What Do You Do?
• Meet with FDA – unless absolutely clear
• Understand that you are in the medical device
business and that, even if you have a Class I
device, you have to meet the General
Controls, which are demanding, especially:
– Quality Systems Regulations
 Design controls for software
• Reimbursement – who will pay for it?
– CMS
– Private payer
51
www.duanemorris.com
Privacy/Security and MHealth
Lisa Clark
52
www.duanemorris.com
Privacy and Security
• The question: What are the required,
recommended and best privacy and security
protections for a particular mHealth product or
service?
– Is the product/service subject to HIPAA?
– Does the FTC guidance apply? Has the FTC initiated an
enforcement action against a similar product/service?
– When is consent to collect/use/disclose data required?
– What other federal or state laws or agencies might regulate the
product/service?
– What are industry best-practices?
53
www.duanemorris.com
Privacy and Security
• The terms:
– ‘Privacy’: protects the consumer through
policies, rights to data, etc.
– ‘Security’: protects the data through
passwords, encryption, etc.
– ‘By Design’: Designing the
product/service with privacy and security
in mind
54
www.duanemorris.com
Privacy and Security
• The principal laws and regulations:
– Health Information Portability and Accountability Act of
1996 (HIPAA)
– Federal Trade Commission Act (consumer fraud,
fairness)
– Federal and state consent laws
– Other privacy and breach laws
– American Reinvestment and Recovery Act –
Meaningful Use regulations
55
www.duanemorris.com
Privacy and Security
• HIPAA:
– Protects the privacy and security of protected health
information (PHI)
– Fines up to $1.5m per year for violations.
– Does HIPAA apply?
 Applies to Covered Entities – 1) health care providers
that engage in certain electronic transactions, 2) health
plans, and 3) health clearinghouses (billing companies)
 Also applies to Business Associates – agents and
subcontractors of Covered Entities that handle PHI, and
their agents and subcontractors
56
www.duanemorris.com
Privacy and Security, HIPAA cont.
• If an entity is not a Covered Entity or Business
Associate, then HIPAA does not apply
– a physician IS a covered entity (and so any app
provided by the physician to patients, e.g., personal
health record that interfaces with physician is covered)
– a data management company that provides services to
a hospital IS a Business Associate
57
www.duanemorris.com
Privacy and Security, HIPAA cont.
• A wireless heart rate monitor service provider that permits a
patient to collect heart rate data at home and send it to his/her
physician
• is NOT a Covered Entity if it does not bill a payor (instead bills the
customer or the provider)
• BUT the physician (who is a Covered Entity) must protect the PHI
• Software that supports the distribution of specialized drugs to a
hospital and include a patient portal provides billing services
• IS a Covered Entity if it bills a payor for the hospital or
individual
• IS also a Business Associate because if it is billing for the
hospital or performing data analysis
• MAY BE a Covered Entity as a Provider
58
www.duanemorris.com
Privacy and Security, HIPAA cont.
• If HIPAA applies, then must implement a
Compliance Program that includes:
– Privacy requirements – Notices, P&Ps,
Training, Rights for Individuals, etc.
– Security ‘standards’ – Access Restrictions,
Audit Requirements, Disaster Recovery, etc.
– Breach Notification – Breach Reporting Policy
59
www.duanemorris.com
Privacy and Security, FTC
• FTC is authorized to protect the consumer
against
– 1) Deception (material misrepresentation, omission);
– 2) Unfairness (harm or the potential for harm)
• Actions:
– PATH social networking app: settled with FTC for
$800k against charges that it deceived users by
collecting personal information from their mobile device
address books without their knowledge and consent.
– AcneApp: agreed to stop advertising baseless claims
that app could cure acne with lights emitted from
smartphones60
www.duanemorris.com
Privacy and Security, FTC Guidance
• “Marketing Your Mobile App: Get It Right from
the Start” business.ftc.gov/documents/bus81-
marketing-your-mobile-app
 Privacy by Design - Build privacy considerations in from the
start.
 Transparency.
 Collect sensitive data with consent.
 Keep data secure.
 Truthful advertising, etc.
- “Mobile Privacy Disclosures: Building Trust Through Transparency”
www.ftc.gov/os/2013/02/130201mobileprivacyreport.pdf
61
www.duanemorris.com
Privacy and Security, FTC Guidance
• “Mobile App Developers: Start with
Security” business.ftc.gov/documents/bus83-mobile-app-
developers-start-security
– Make someone responsible.
– Take stock of the data.
– Understand differences between mobile platforms.
– Use due diligence on third party code.
– Use transit encryption for usernames, passwords, and other
important data.
– Protect your services, etc.
62
www.duanemorris.com
Privacy and Security, Sensitive Data
and Consent
• When is consent to collect/use/disclose
‘sensitive data’ required?
– ‘Sensitive data’ includes: mental health, substance
abuse, reproductive health, genetic, infectious disease
and other data.
– Different laws apply.
– Consent may be obtained in writing, through opt-in/opt-
out, etc. – verbal not advised.
– Consent must be clear and honored.
63
www.duanemorris.com
Privacy and Security, Social Media
• What is ‘social media’?
– Forms of exchange of user-generated content,
including blogging, chat rooms, internet forums,
podcasts, instant messaging, etc.
• Principle is free-flow of information (and thus difficult
to control privacy and security).
• No separate laws (yet).
• If mHealth product/service uses social media (e.g., an
app that links to a chat room), must ensure
transparency of how data used, obtained consent as
necessary, etc.
64
www.duanemorris.com
Privacy and Security, Other Resources
• HHS’s Office of National Coordinator
www.healthit.gov (authorized by ARRA to
oversee development of HIT):
– Development of Nationwide Privacy and Security
Framework for National Health Information Exchange
(HIE)
 Privacy and security at every level.
– Examining conflicting state laws around consent.
– Developing toolkits.
65
www.duanemorris.com
Privacy and Security,
Recommendations
• To determine best industry privacy and security
practices, work with industry groups, consultants.
• General resources:
– mHIMSS, www.mhimss.org
– AHIMA, www.ahima.org
• Obtain legal advice regarding applicable laws (HIPAA,
FTC, sensitive data, breach, etc.) and whether the
product/service’s privacy and security compliance
program satisfies those laws.
66
www.duanemorris.com
Questions?
• Ken Keane, Partner, Duane Morris
– Phone: +1 202 776 5243
Email: KKeane@duanemorris.com
• Lisa Clark, Partner, Duane Morris
– Phone: +1 215 979 1833
Email: LWClark@duanemorris.com
• Michael Swit, Special Counsel, Duane Morris
– Phone: +1 619 744 2215
Email: MASwit@duanemorris.com
67

More Related Content

What's hot

Wireless health market
Wireless health marketWireless health market
Wireless health market
ameliasimon0
 
eHealth and mhealth presentation
eHealth and mhealth presentationeHealth and mhealth presentation
eHealth and mhealth presentation
Erik Vollebregt
 
A governance model for ubiquitous medical devices accessing eHealth data: the...
A governance model for ubiquitous medical devices accessing eHealth data: the...A governance model for ubiquitous medical devices accessing eHealth data: the...
A governance model for ubiquitous medical devices accessing eHealth data: the...
Massimiliano Masi
 
IRDAI - NHA Joint Working Group: Sub Group on IT
IRDAI - NHA Joint Working Group: Sub Group on ITIRDAI - NHA Joint Working Group: Sub Group on IT
IRDAI - NHA Joint Working Group: Sub Group on IT
Pankaj Gupta
 
Protecting Privacy, Security and Patient Safety in mHealth
Protecting Privacy, Security and Patient Safety in mHealthProtecting Privacy, Security and Patient Safety in mHealth
Protecting Privacy, Security and Patient Safety in mHealth
TAOklahoma
 
Global interventional cardiology market 2017-2022 sample report
Global interventional cardiology market 2017-2022 sample reportGlobal interventional cardiology market 2017-2022 sample report
Global interventional cardiology market 2017-2022 sample report
Netscribes, Inc.
 
Wireless Medical Devices
Wireless Medical DevicesWireless Medical Devices
Wireless Medical Devices
EMMAIntl
 
Global telehealth market 2014 2022 sample pages
Global telehealth market 2014 2022 sample pagesGlobal telehealth market 2014 2022 sample pages
Global telehealth market 2014 2022 sample pages
Netscribes, Inc.
 
Establishing Cognizant In EMR Market
Establishing Cognizant In EMR MarketEstablishing Cognizant In EMR Market
Establishing Cognizant In EMR Market
Eternaljoy
 
TeleHealth: Today and Tomorrow - Some Basics
TeleHealth: Today and Tomorrow - Some BasicsTeleHealth: Today and Tomorrow - Some Basics
TeleHealth: Today and Tomorrow - Some Basics
Ron Huber
 
Transparency under the new MDR and IVDR
Transparency under the new MDR and IVDRTransparency under the new MDR and IVDR
Transparency under the new MDR and IVDR
Erik Vollebregt
 
Use of left over samples under the IVDR and GDPR
Use of left over samples under the IVDR and GDPRUse of left over samples under the IVDR and GDPR
Use of left over samples under the IVDR and GDPR
Erik Vollebregt
 
Hip hiu policy
Hip hiu policyHip hiu policy
Hip hiu policy
Manish Nachnani
 
Advamed MDR IVDR update
Advamed MDR IVDR updateAdvamed MDR IVDR update
Advamed MDR IVDR update
Erik Vollebregt
 
Recent and future developments in UDI for medical devices in the EU
Recent and future developments in UDI for medical devices in the EURecent and future developments in UDI for medical devices in the EU
Recent and future developments in UDI for medical devices in the EU
Erik Vollebregt
 
Prior Authorization For Radiology By SunKnowledge
Prior Authorization For Radiology By SunKnowledgePrior Authorization For Radiology By SunKnowledge
Prior Authorization For Radiology By SunKnowledge
Ronnie Hastings
 
The Open Source Revolution
The Open Source RevolutionThe Open Source Revolution
The Open Source Revolution
Jack Shaffer
 
maurice mars
maurice marsmaurice mars
maurice mars
THCwIT Conference
 
Elliot virtech-temeo
Elliot virtech-temeoElliot virtech-temeo
Cscu module 12 information security and legal compliance
Cscu module 12 information security and legal complianceCscu module 12 information security and legal compliance
Cscu module 12 information security and legal compliance
Alireza Ghahrood
 

What's hot (20)

Wireless health market
Wireless health marketWireless health market
Wireless health market
 
eHealth and mhealth presentation
eHealth and mhealth presentationeHealth and mhealth presentation
eHealth and mhealth presentation
 
A governance model for ubiquitous medical devices accessing eHealth data: the...
A governance model for ubiquitous medical devices accessing eHealth data: the...A governance model for ubiquitous medical devices accessing eHealth data: the...
A governance model for ubiquitous medical devices accessing eHealth data: the...
 
IRDAI - NHA Joint Working Group: Sub Group on IT
IRDAI - NHA Joint Working Group: Sub Group on ITIRDAI - NHA Joint Working Group: Sub Group on IT
IRDAI - NHA Joint Working Group: Sub Group on IT
 
Protecting Privacy, Security and Patient Safety in mHealth
Protecting Privacy, Security and Patient Safety in mHealthProtecting Privacy, Security and Patient Safety in mHealth
Protecting Privacy, Security and Patient Safety in mHealth
 
Global interventional cardiology market 2017-2022 sample report
Global interventional cardiology market 2017-2022 sample reportGlobal interventional cardiology market 2017-2022 sample report
Global interventional cardiology market 2017-2022 sample report
 
Wireless Medical Devices
Wireless Medical DevicesWireless Medical Devices
Wireless Medical Devices
 
Global telehealth market 2014 2022 sample pages
Global telehealth market 2014 2022 sample pagesGlobal telehealth market 2014 2022 sample pages
Global telehealth market 2014 2022 sample pages
 
Establishing Cognizant In EMR Market
Establishing Cognizant In EMR MarketEstablishing Cognizant In EMR Market
Establishing Cognizant In EMR Market
 
TeleHealth: Today and Tomorrow - Some Basics
TeleHealth: Today and Tomorrow - Some BasicsTeleHealth: Today and Tomorrow - Some Basics
TeleHealth: Today and Tomorrow - Some Basics
 
Transparency under the new MDR and IVDR
Transparency under the new MDR and IVDRTransparency under the new MDR and IVDR
Transparency under the new MDR and IVDR
 
Use of left over samples under the IVDR and GDPR
Use of left over samples under the IVDR and GDPRUse of left over samples under the IVDR and GDPR
Use of left over samples under the IVDR and GDPR
 
Hip hiu policy
Hip hiu policyHip hiu policy
Hip hiu policy
 
Advamed MDR IVDR update
Advamed MDR IVDR updateAdvamed MDR IVDR update
Advamed MDR IVDR update
 
Recent and future developments in UDI for medical devices in the EU
Recent and future developments in UDI for medical devices in the EURecent and future developments in UDI for medical devices in the EU
Recent and future developments in UDI for medical devices in the EU
 
Prior Authorization For Radiology By SunKnowledge
Prior Authorization For Radiology By SunKnowledgePrior Authorization For Radiology By SunKnowledge
Prior Authorization For Radiology By SunKnowledge
 
The Open Source Revolution
The Open Source RevolutionThe Open Source Revolution
The Open Source Revolution
 
maurice mars
maurice marsmaurice mars
maurice mars
 
Elliot virtech-temeo
Elliot virtech-temeoElliot virtech-temeo
Elliot virtech-temeo
 
Cscu module 12 information security and legal compliance
Cscu module 12 information security and legal complianceCscu module 12 information security and legal compliance
Cscu module 12 information security and legal compliance
 

Similar to mHealth Converges: The Impact of FCC, HIPAA/Privacy and FDA

Leveraging emerging standards for patient engagement pcha
Leveraging emerging standards for patient engagement pchaLeveraging emerging standards for patient engagement pcha
Leveraging emerging standards for patient engagement pcha
mHealth2015
 
IIM BLR Smart Product & Deep Tech Strategy Healthcare 40 BANI world.pdf
IIM BLR Smart Product & Deep Tech Strategy Healthcare 40 BANI world.pdfIIM BLR Smart Product & Deep Tech Strategy Healthcare 40 BANI world.pdf
IIM BLR Smart Product & Deep Tech Strategy Healthcare 40 BANI world.pdf
ISPMAIndia
 
Apply Computer and Mobile Health Technology.pptx
Apply Computer and Mobile Health Technology.pptxApply Computer and Mobile Health Technology.pptx
Apply Computer and Mobile Health Technology.pptx
dereje33
 
Mobile Health Symposium #HIMSS15 Session Mh5
Mobile Health Symposium #HIMSS15 Session Mh5Mobile Health Symposium #HIMSS15 Session Mh5
Mobile Health Symposium #HIMSS15 Session Mh5
3GDR
 
Deployed eHealth solutions in Morocco_ ELKAFIL_MOROCCO.pptx
Deployed eHealth solutions in Morocco_ ELKAFIL_MOROCCO.pptxDeployed eHealth solutions in Morocco_ ELKAFIL_MOROCCO.pptx
Deployed eHealth solutions in Morocco_ ELKAFIL_MOROCCO.pptx
HORIYASOFT
 
Ehr driven his jan 2016
Ehr driven his jan 2016Ehr driven his jan 2016
Ehr driven his jan 2016
Anil Patil
 
Midwest Regional Health - EHR
Midwest Regional Health - EHRMidwest Regional Health - EHR
Midwest Regional Health - EHR
WILLIE GREER
 
Presentation: Device vigilance - local challenges & global trends
Presentation: Device vigilance - local challenges & global trendsPresentation: Device vigilance - local challenges & global trends
Presentation: Device vigilance - local challenges & global trends
TGA Australia
 
Telecommunication systems applied to telemedicine
Telecommunication systems applied to telemedicineTelecommunication systems applied to telemedicine
Telecommunication systems applied to telemedicine
Shazia Iqbal
 
Use of mobile device in health care setting
Use of mobile device in health care settingUse of mobile device in health care setting
Use of mobile device in health care setting
Dr. Samir Sawli
 
Mobile Health Symposium #HIMSS15 Session Mh1
Mobile Health Symposium #HIMSS15 Session Mh1Mobile Health Symposium #HIMSS15 Session Mh1
Mobile Health Symposium #HIMSS15 Session Mh1
3GDR
 
HXR 2016: The Health IoT: Remote Care and Mobile Solutions -Andrew Hooge, Val...
HXR 2016: The Health IoT: Remote Care and Mobile Solutions -Andrew Hooge, Val...HXR 2016: The Health IoT: Remote Care and Mobile Solutions -Andrew Hooge, Val...
HXR 2016: The Health IoT: Remote Care and Mobile Solutions -Andrew Hooge, Val...
HxRefactored
 
2016 PLCT PPT - PRODUCT MALFUNCTION THEORY WHEN “SMART” PRODUCTS ACT DUMB
2016 PLCT PPT - PRODUCT MALFUNCTION THEORY WHEN “SMART” PRODUCTS ACT DUMB2016 PLCT PPT - PRODUCT MALFUNCTION THEORY WHEN “SMART” PRODUCTS ACT DUMB
2016 PLCT PPT - PRODUCT MALFUNCTION THEORY WHEN “SMART” PRODUCTS ACT DUMBRob Smith
 
Telemedicine in ksa 27.12.2020
Telemedicine in ksa  27.12.2020Telemedicine in ksa  27.12.2020
Telemedicine in ksa 27.12.2020
Shazia Iqbal
 
MiHIN Overview - Health Information Exchange Meet and Greet v7 10 22-14
MiHIN Overview - Health Information Exchange Meet and Greet v7 10 22-14MiHIN Overview - Health Information Exchange Meet and Greet v7 10 22-14
MiHIN Overview - Health Information Exchange Meet and Greet v7 10 22-14
mihinpr
 
SeHF 2014 | Tackling the Tsunami: Building an mHealth Strategy
SeHF 2014 | Tackling the Tsunami: Building an mHealth StrategySeHF 2014 | Tackling the Tsunami: Building an mHealth Strategy
SeHF 2014 | Tackling the Tsunami: Building an mHealth StrategySwiss eHealth Forum
 
Health Information Systems
Health Information SystemsHealth Information Systems
Health Information SystemsNikhil Agarwal
 
System Request FormDateProject Name Centralizing Medic.docx
System Request FormDateProject Name Centralizing Medic.docxSystem Request FormDateProject Name Centralizing Medic.docx
System Request FormDateProject Name Centralizing Medic.docx
mattinsonjanel
 
How good we are in adhering HIPAA rules
How good we are in adhering HIPAA rulesHow good we are in adhering HIPAA rules
How good we are in adhering HIPAA rules
Medical Transcriptions Service
 

Similar to mHealth Converges: The Impact of FCC, HIPAA/Privacy and FDA (20)

Leveraging emerging standards for patient engagement pcha
Leveraging emerging standards for patient engagement pchaLeveraging emerging standards for patient engagement pcha
Leveraging emerging standards for patient engagement pcha
 
IIM BLR Smart Product & Deep Tech Strategy Healthcare 40 BANI world.pdf
IIM BLR Smart Product & Deep Tech Strategy Healthcare 40 BANI world.pdfIIM BLR Smart Product & Deep Tech Strategy Healthcare 40 BANI world.pdf
IIM BLR Smart Product & Deep Tech Strategy Healthcare 40 BANI world.pdf
 
Apply Computer and Mobile Health Technology.pptx
Apply Computer and Mobile Health Technology.pptxApply Computer and Mobile Health Technology.pptx
Apply Computer and Mobile Health Technology.pptx
 
Mobile Health Symposium #HIMSS15 Session Mh5
Mobile Health Symposium #HIMSS15 Session Mh5Mobile Health Symposium #HIMSS15 Session Mh5
Mobile Health Symposium #HIMSS15 Session Mh5
 
Deployed eHealth solutions in Morocco_ ELKAFIL_MOROCCO.pptx
Deployed eHealth solutions in Morocco_ ELKAFIL_MOROCCO.pptxDeployed eHealth solutions in Morocco_ ELKAFIL_MOROCCO.pptx
Deployed eHealth solutions in Morocco_ ELKAFIL_MOROCCO.pptx
 
Ehr driven his jan 2016
Ehr driven his jan 2016Ehr driven his jan 2016
Ehr driven his jan 2016
 
Midwest Regional Health - EHR
Midwest Regional Health - EHRMidwest Regional Health - EHR
Midwest Regional Health - EHR
 
Presentation: Device vigilance - local challenges & global trends
Presentation: Device vigilance - local challenges & global trendsPresentation: Device vigilance - local challenges & global trends
Presentation: Device vigilance - local challenges & global trends
 
Telecommunication systems applied to telemedicine
Telecommunication systems applied to telemedicineTelecommunication systems applied to telemedicine
Telecommunication systems applied to telemedicine
 
Use of mobile device in health care setting
Use of mobile device in health care settingUse of mobile device in health care setting
Use of mobile device in health care setting
 
Mobile Health Symposium #HIMSS15 Session Mh1
Mobile Health Symposium #HIMSS15 Session Mh1Mobile Health Symposium #HIMSS15 Session Mh1
Mobile Health Symposium #HIMSS15 Session Mh1
 
Rfid in health care
Rfid in health careRfid in health care
Rfid in health care
 
HXR 2016: The Health IoT: Remote Care and Mobile Solutions -Andrew Hooge, Val...
HXR 2016: The Health IoT: Remote Care and Mobile Solutions -Andrew Hooge, Val...HXR 2016: The Health IoT: Remote Care and Mobile Solutions -Andrew Hooge, Val...
HXR 2016: The Health IoT: Remote Care and Mobile Solutions -Andrew Hooge, Val...
 
2016 PLCT PPT - PRODUCT MALFUNCTION THEORY WHEN “SMART” PRODUCTS ACT DUMB
2016 PLCT PPT - PRODUCT MALFUNCTION THEORY WHEN “SMART” PRODUCTS ACT DUMB2016 PLCT PPT - PRODUCT MALFUNCTION THEORY WHEN “SMART” PRODUCTS ACT DUMB
2016 PLCT PPT - PRODUCT MALFUNCTION THEORY WHEN “SMART” PRODUCTS ACT DUMB
 
Telemedicine in ksa 27.12.2020
Telemedicine in ksa  27.12.2020Telemedicine in ksa  27.12.2020
Telemedicine in ksa 27.12.2020
 
MiHIN Overview - Health Information Exchange Meet and Greet v7 10 22-14
MiHIN Overview - Health Information Exchange Meet and Greet v7 10 22-14MiHIN Overview - Health Information Exchange Meet and Greet v7 10 22-14
MiHIN Overview - Health Information Exchange Meet and Greet v7 10 22-14
 
SeHF 2014 | Tackling the Tsunami: Building an mHealth Strategy
SeHF 2014 | Tackling the Tsunami: Building an mHealth StrategySeHF 2014 | Tackling the Tsunami: Building an mHealth Strategy
SeHF 2014 | Tackling the Tsunami: Building an mHealth Strategy
 
Health Information Systems
Health Information SystemsHealth Information Systems
Health Information Systems
 
System Request FormDateProject Name Centralizing Medic.docx
System Request FormDateProject Name Centralizing Medic.docxSystem Request FormDateProject Name Centralizing Medic.docx
System Request FormDateProject Name Centralizing Medic.docx
 
How good we are in adhering HIPAA rules
How good we are in adhering HIPAA rulesHow good we are in adhering HIPAA rules
How good we are in adhering HIPAA rules
 

More from Michael Swit

GMP Review -- Legal Letter from America Column -- How Data Integrity Issues S...
GMP Review -- Legal Letter from America Column -- How Data Integrity Issues S...GMP Review -- Legal Letter from America Column -- How Data Integrity Issues S...
GMP Review -- Legal Letter from America Column -- How Data Integrity Issues S...
Michael Swit
 
FDA Regulation of Promotion & Advertising -- Part 8: Handling Promotional Com...
FDA Regulation of Promotion & Advertising -- Part 8: Handling Promotional Com...FDA Regulation of Promotion & Advertising -- Part 8: Handling Promotional Com...
FDA Regulation of Promotion & Advertising -- Part 8: Handling Promotional Com...
Michael Swit
 
FDA Regulation of Promotion & Advertising -- Part 7: FTC Regulation
FDA Regulation of Promotion & Advertising -- Part 7: FTC RegulationFDA Regulation of Promotion & Advertising -- Part 7: FTC Regulation
FDA Regulation of Promotion & Advertising -- Part 7: FTC Regulation
Michael Swit
 
FDA Regulation of Promotion & Advertising -- Part 6: First Amendment, Off-Lab...
FDA Regulation of Promotion & Advertising -- Part 6: First Amendment, Off-Lab...FDA Regulation of Promotion & Advertising -- Part 6: First Amendment, Off-Lab...
FDA Regulation of Promotion & Advertising -- Part 6: First Amendment, Off-Lab...
Michael Swit
 
FDA Regulation of Promotion & Advertising -- Part 5: Social Media & Internet
FDA Regulation of Promotion & Advertising -- Part 5: Social Media & InternetFDA Regulation of Promotion & Advertising -- Part 5: Social Media & Internet
FDA Regulation of Promotion & Advertising -- Part 5: Social Media & Internet
Michael Swit
 
FDA Regulation of Promotion & Advertising -- Part 4: FDA Enforcement – Action...
FDA Regulation of Promotion & Advertising -- Part 4: FDA Enforcement – Action...FDA Regulation of Promotion & Advertising -- Part 4: FDA Enforcement – Action...
FDA Regulation of Promotion & Advertising -- Part 4: FDA Enforcement – Action...
Michael Swit
 
FDA Regulation of Promotion & Advertising -- Part 3: Disseminating Scientific...
FDA Regulation of Promotion & Advertising -- Part 3: Disseminating Scientific...FDA Regulation of Promotion & Advertising -- Part 3: Disseminating Scientific...
FDA Regulation of Promotion & Advertising -- Part 3: Disseminating Scientific...
Michael Swit
 
FDA Regulation of Promotion & Advertising --Part 2: Direct-to-Consumer Ads
FDA Regulation of Promotion & Advertising --Part 2: Direct-to-Consumer AdsFDA Regulation of Promotion & Advertising --Part 2: Direct-to-Consumer Ads
FDA Regulation of Promotion & Advertising --Part 2: Direct-to-Consumer Ads
Michael Swit
 
FDA Regulation of Promotion & Advertising -- Part 1: The Basics
FDA Regulation of Promotion & Advertising -- Part 1: The BasicsFDA Regulation of Promotion & Advertising -- Part 1: The Basics
FDA Regulation of Promotion & Advertising -- Part 1: The Basics
Michael Swit
 
Ensuring FDA Regulatory Success for Biomedical Companies -- Key Lessons for S...
Ensuring FDA Regulatory Success for Biomedical Companies -- Key Lessons for S...Ensuring FDA Regulatory Success for Biomedical Companies -- Key Lessons for S...
Ensuring FDA Regulatory Success for Biomedical Companies -- Key Lessons for S...
Michael Swit
 
Regulatory, Quality & Clinical Due Diligence: The Oft Overlooked Keys to Suc...
Regulatory, Quality & Clinical Due Diligence:  The Oft Overlooked Keys to Suc...Regulatory, Quality & Clinical Due Diligence:  The Oft Overlooked Keys to Suc...
Regulatory, Quality & Clinical Due Diligence: The Oft Overlooked Keys to Suc...
Michael Swit
 
Quality Considerations in Due Diligence for Pharmaceutical Transactions
Quality Considerations in Due Diligence for Pharmaceutical TransactionsQuality Considerations in Due Diligence for Pharmaceutical Transactions
Quality Considerations in Due Diligence for Pharmaceutical Transactions
Michael Swit
 
FDA Inspections: Handling the Administrative and Legal Consequences -- Under...
FDA Inspections:  Handling the Administrative and Legal Consequences -- Under...FDA Inspections:  Handling the Administrative and Legal Consequences -- Under...
FDA Inspections: Handling the Administrative and Legal Consequences -- Under...
Michael Swit
 
FDA Regulation of Advertising of Diagnostics, RUO Products, and Laboratory De...
FDA Regulation of Advertising of Diagnostics, RUO Products, and Laboratory De...FDA Regulation of Advertising of Diagnostics, RUO Products, and Laboratory De...
FDA Regulation of Advertising of Diagnostics, RUO Products, and Laboratory De...
Michael Swit
 
Basics of FDA Regulation of Device & IVD Advertising
Basics of FDA Regulation of Device & IVD AdvertisingBasics of FDA Regulation of Device & IVD Advertising
Basics of FDA Regulation of Device & IVD Advertising
Michael Swit
 
Presentation on Critical Legal Issues Facing GMP Compliance
Presentation on Critical Legal Issues Facing GMP CompliancePresentation on Critical Legal Issues Facing GMP Compliance
Presentation on Critical Legal Issues Facing GMP Compliance
Michael Swit
 
Overview of FDA Drug Manufacturing Requirements
Overview of FDA Drug Manufacturing RequirementsOverview of FDA Drug Manufacturing Requirements
Overview of FDA Drug Manufacturing Requirements
Michael Swit
 
"Scientific Exchange -- New Interpretations??"
"Scientific Exchange -- New Interpretations??""Scientific Exchange -- New Interpretations??"
"Scientific Exchange -- New Interpretations??"
Michael Swit
 
Combination Products, Orphan Drugs, and OTC Drugs
Combination Products, Orphan Drugs, and OTC DrugsCombination Products, Orphan Drugs, and OTC Drugs
Combination Products, Orphan Drugs, and OTC Drugs
Michael Swit
 
Latest Developments in and the Future of the Regulatory Landscape for Approv...
Latest Developments in and the Future of the  Regulatory Landscape for Approv...Latest Developments in and the Future of the  Regulatory Landscape for Approv...
Latest Developments in and the Future of the Regulatory Landscape for Approv...
Michael Swit
 

More from Michael Swit (20)

GMP Review -- Legal Letter from America Column -- How Data Integrity Issues S...
GMP Review -- Legal Letter from America Column -- How Data Integrity Issues S...GMP Review -- Legal Letter from America Column -- How Data Integrity Issues S...
GMP Review -- Legal Letter from America Column -- How Data Integrity Issues S...
 
FDA Regulation of Promotion & Advertising -- Part 8: Handling Promotional Com...
FDA Regulation of Promotion & Advertising -- Part 8: Handling Promotional Com...FDA Regulation of Promotion & Advertising -- Part 8: Handling Promotional Com...
FDA Regulation of Promotion & Advertising -- Part 8: Handling Promotional Com...
 
FDA Regulation of Promotion & Advertising -- Part 7: FTC Regulation
FDA Regulation of Promotion & Advertising -- Part 7: FTC RegulationFDA Regulation of Promotion & Advertising -- Part 7: FTC Regulation
FDA Regulation of Promotion & Advertising -- Part 7: FTC Regulation
 
FDA Regulation of Promotion & Advertising -- Part 6: First Amendment, Off-Lab...
FDA Regulation of Promotion & Advertising -- Part 6: First Amendment, Off-Lab...FDA Regulation of Promotion & Advertising -- Part 6: First Amendment, Off-Lab...
FDA Regulation of Promotion & Advertising -- Part 6: First Amendment, Off-Lab...
 
FDA Regulation of Promotion & Advertising -- Part 5: Social Media & Internet
FDA Regulation of Promotion & Advertising -- Part 5: Social Media & InternetFDA Regulation of Promotion & Advertising -- Part 5: Social Media & Internet
FDA Regulation of Promotion & Advertising -- Part 5: Social Media & Internet
 
FDA Regulation of Promotion & Advertising -- Part 4: FDA Enforcement – Action...
FDA Regulation of Promotion & Advertising -- Part 4: FDA Enforcement – Action...FDA Regulation of Promotion & Advertising -- Part 4: FDA Enforcement – Action...
FDA Regulation of Promotion & Advertising -- Part 4: FDA Enforcement – Action...
 
FDA Regulation of Promotion & Advertising -- Part 3: Disseminating Scientific...
FDA Regulation of Promotion & Advertising -- Part 3: Disseminating Scientific...FDA Regulation of Promotion & Advertising -- Part 3: Disseminating Scientific...
FDA Regulation of Promotion & Advertising -- Part 3: Disseminating Scientific...
 
FDA Regulation of Promotion & Advertising --Part 2: Direct-to-Consumer Ads
FDA Regulation of Promotion & Advertising --Part 2: Direct-to-Consumer AdsFDA Regulation of Promotion & Advertising --Part 2: Direct-to-Consumer Ads
FDA Regulation of Promotion & Advertising --Part 2: Direct-to-Consumer Ads
 
FDA Regulation of Promotion & Advertising -- Part 1: The Basics
FDA Regulation of Promotion & Advertising -- Part 1: The BasicsFDA Regulation of Promotion & Advertising -- Part 1: The Basics
FDA Regulation of Promotion & Advertising -- Part 1: The Basics
 
Ensuring FDA Regulatory Success for Biomedical Companies -- Key Lessons for S...
Ensuring FDA Regulatory Success for Biomedical Companies -- Key Lessons for S...Ensuring FDA Regulatory Success for Biomedical Companies -- Key Lessons for S...
Ensuring FDA Regulatory Success for Biomedical Companies -- Key Lessons for S...
 
Regulatory, Quality & Clinical Due Diligence: The Oft Overlooked Keys to Suc...
Regulatory, Quality & Clinical Due Diligence:  The Oft Overlooked Keys to Suc...Regulatory, Quality & Clinical Due Diligence:  The Oft Overlooked Keys to Suc...
Regulatory, Quality & Clinical Due Diligence: The Oft Overlooked Keys to Suc...
 
Quality Considerations in Due Diligence for Pharmaceutical Transactions
Quality Considerations in Due Diligence for Pharmaceutical TransactionsQuality Considerations in Due Diligence for Pharmaceutical Transactions
Quality Considerations in Due Diligence for Pharmaceutical Transactions
 
FDA Inspections: Handling the Administrative and Legal Consequences -- Under...
FDA Inspections:  Handling the Administrative and Legal Consequences -- Under...FDA Inspections:  Handling the Administrative and Legal Consequences -- Under...
FDA Inspections: Handling the Administrative and Legal Consequences -- Under...
 
FDA Regulation of Advertising of Diagnostics, RUO Products, and Laboratory De...
FDA Regulation of Advertising of Diagnostics, RUO Products, and Laboratory De...FDA Regulation of Advertising of Diagnostics, RUO Products, and Laboratory De...
FDA Regulation of Advertising of Diagnostics, RUO Products, and Laboratory De...
 
Basics of FDA Regulation of Device & IVD Advertising
Basics of FDA Regulation of Device & IVD AdvertisingBasics of FDA Regulation of Device & IVD Advertising
Basics of FDA Regulation of Device & IVD Advertising
 
Presentation on Critical Legal Issues Facing GMP Compliance
Presentation on Critical Legal Issues Facing GMP CompliancePresentation on Critical Legal Issues Facing GMP Compliance
Presentation on Critical Legal Issues Facing GMP Compliance
 
Overview of FDA Drug Manufacturing Requirements
Overview of FDA Drug Manufacturing RequirementsOverview of FDA Drug Manufacturing Requirements
Overview of FDA Drug Manufacturing Requirements
 
"Scientific Exchange -- New Interpretations??"
"Scientific Exchange -- New Interpretations??""Scientific Exchange -- New Interpretations??"
"Scientific Exchange -- New Interpretations??"
 
Combination Products, Orphan Drugs, and OTC Drugs
Combination Products, Orphan Drugs, and OTC DrugsCombination Products, Orphan Drugs, and OTC Drugs
Combination Products, Orphan Drugs, and OTC Drugs
 
Latest Developments in and the Future of the Regulatory Landscape for Approv...
Latest Developments in and the Future of the  Regulatory Landscape for Approv...Latest Developments in and the Future of the  Regulatory Landscape for Approv...
Latest Developments in and the Future of the Regulatory Landscape for Approv...
 

Recently uploaded

怎么购买(massey毕业证书)新西兰梅西大学毕业证学位证书注册证明信原版一模一样
怎么购买(massey毕业证书)新西兰梅西大学毕业证学位证书注册证明信原版一模一样怎么购买(massey毕业证书)新西兰梅西大学毕业证学位证书注册证明信原版一模一样
怎么购买(massey毕业证书)新西兰梅西大学毕业证学位证书注册证明信原版一模一样
9ib5wiwt
 
new victimology of indonesian law. Pptx.
new victimology of indonesian law. Pptx.new victimology of indonesian law. Pptx.
new victimology of indonesian law. Pptx.
niputusriwidiasih
 
1比1制作(swansea毕业证书)英国斯旺西大学毕业证学位证书托业成绩单原版一模一样
1比1制作(swansea毕业证书)英国斯旺西大学毕业证学位证书托业成绩单原版一模一样1比1制作(swansea毕业证书)英国斯旺西大学毕业证学位证书托业成绩单原版一模一样
1比1制作(swansea毕业证书)英国斯旺西大学毕业证学位证书托业成绩单原版一模一样
9ib5wiwt
 
How to Obtain Permanent Residency in the Netherlands
How to Obtain Permanent Residency in the NetherlandsHow to Obtain Permanent Residency in the Netherlands
How to Obtain Permanent Residency in the Netherlands
BridgeWest.eu
 
EMPLOYMENT LAW AN OVERVIEW in Malawi.pptx
EMPLOYMENT LAW  AN OVERVIEW in Malawi.pptxEMPLOYMENT LAW  AN OVERVIEW in Malawi.pptx
EMPLOYMENT LAW AN OVERVIEW in Malawi.pptx
MwaiMapemba
 
Notes-on-Prescription-Obligations-and-Contracts.doc
Notes-on-Prescription-Obligations-and-Contracts.docNotes-on-Prescription-Obligations-and-Contracts.doc
Notes-on-Prescription-Obligations-and-Contracts.doc
BRELGOSIMAT
 
WINDING UP of COMPANY, Modes of Dissolution
WINDING UP of COMPANY, Modes of DissolutionWINDING UP of COMPANY, Modes of Dissolution
WINDING UP of COMPANY, Modes of Dissolution
KHURRAMWALI
 
The Reserve Bank of India Act, 1934.pptx
The Reserve Bank of India Act, 1934.pptxThe Reserve Bank of India Act, 1934.pptx
The Reserve Bank of India Act, 1934.pptx
nehatalele22st
 
Daftar Rumpun, Pohon, dan Cabang Ilmu (28 Mei 2024).pdf
Daftar Rumpun, Pohon, dan Cabang Ilmu (28 Mei 2024).pdfDaftar Rumpun, Pohon, dan Cabang Ilmu (28 Mei 2024).pdf
Daftar Rumpun, Pohon, dan Cabang Ilmu (28 Mei 2024).pdf
akbarrasyid3
 
Highlights_of_Bhartiya_Nyaya_Sanhita.pptx
Highlights_of_Bhartiya_Nyaya_Sanhita.pptxHighlights_of_Bhartiya_Nyaya_Sanhita.pptx
Highlights_of_Bhartiya_Nyaya_Sanhita.pptx
anjalidixit21
 
定制(nus毕业证书)新加坡国立大学毕业证学位证书实拍图原版一模一样
定制(nus毕业证书)新加坡国立大学毕业证学位证书实拍图原版一模一样定制(nus毕业证书)新加坡国立大学毕业证学位证书实拍图原版一模一样
定制(nus毕业证书)新加坡国立大学毕业证学位证书实拍图原版一模一样
9ib5wiwt
 
Rokita Releases Soccer Stadium Legal Opinion
Rokita Releases Soccer Stadium Legal OpinionRokita Releases Soccer Stadium Legal Opinion
Rokita Releases Soccer Stadium Legal Opinion
Abdul-Hakim Shabazz
 
XYZ-v.-state-of-Maharashtra-Bombay-HC-Writ-Petition-6340-2023.pdf
XYZ-v.-state-of-Maharashtra-Bombay-HC-Writ-Petition-6340-2023.pdfXYZ-v.-state-of-Maharashtra-Bombay-HC-Writ-Petition-6340-2023.pdf
XYZ-v.-state-of-Maharashtra-Bombay-HC-Writ-Petition-6340-2023.pdf
bhavenpr
 
办理(waikato毕业证书)新西兰怀卡托大学毕业证双学位证书原版一模一样
办理(waikato毕业证书)新西兰怀卡托大学毕业证双学位证书原版一模一样办理(waikato毕业证书)新西兰怀卡托大学毕业证双学位证书原版一模一样
办理(waikato毕业证书)新西兰怀卡托大学毕业证双学位证书原版一模一样
9ib5wiwt
 
Agrarian Reform Policies in the Philippines: a quiz
Agrarian Reform Policies in the Philippines: a quizAgrarian Reform Policies in the Philippines: a quiz
Agrarian Reform Policies in the Philippines: a quiz
gaelcabigunda
 
ALL EYES ON RAFAH BUT WHY Explain more.pdf
ALL EYES ON RAFAH BUT WHY Explain more.pdfALL EYES ON RAFAH BUT WHY Explain more.pdf
ALL EYES ON RAFAH BUT WHY Explain more.pdf
46adnanshahzad
 
Responsibilities of the office bearers while registering multi-state cooperat...
Responsibilities of the office bearers while registering multi-state cooperat...Responsibilities of the office bearers while registering multi-state cooperat...
Responsibilities of the office bearers while registering multi-state cooperat...
Finlaw Consultancy Pvt Ltd
 
Donald_J_Trump_katigoritirio_stormi_daniels.pdf
Donald_J_Trump_katigoritirio_stormi_daniels.pdfDonald_J_Trump_katigoritirio_stormi_daniels.pdf
Donald_J_Trump_katigoritirio_stormi_daniels.pdf
ssuser5750e1
 
NATURE, ORIGIN AND DEVELOPMENT OF INTERNATIONAL LAW.pptx
NATURE, ORIGIN AND DEVELOPMENT OF INTERNATIONAL LAW.pptxNATURE, ORIGIN AND DEVELOPMENT OF INTERNATIONAL LAW.pptx
NATURE, ORIGIN AND DEVELOPMENT OF INTERNATIONAL LAW.pptx
anvithaav
 
原版仿制(aut毕业证书)新西兰奥克兰理工大学毕业证文凭毕业证雅思成绩单原版一模一样
原版仿制(aut毕业证书)新西兰奥克兰理工大学毕业证文凭毕业证雅思成绩单原版一模一样原版仿制(aut毕业证书)新西兰奥克兰理工大学毕业证文凭毕业证雅思成绩单原版一模一样
原版仿制(aut毕业证书)新西兰奥克兰理工大学毕业证文凭毕业证雅思成绩单原版一模一样
9ib5wiwt
 

Recently uploaded (20)

怎么购买(massey毕业证书)新西兰梅西大学毕业证学位证书注册证明信原版一模一样
怎么购买(massey毕业证书)新西兰梅西大学毕业证学位证书注册证明信原版一模一样怎么购买(massey毕业证书)新西兰梅西大学毕业证学位证书注册证明信原版一模一样
怎么购买(massey毕业证书)新西兰梅西大学毕业证学位证书注册证明信原版一模一样
 
new victimology of indonesian law. Pptx.
new victimology of indonesian law. Pptx.new victimology of indonesian law. Pptx.
new victimology of indonesian law. Pptx.
 
1比1制作(swansea毕业证书)英国斯旺西大学毕业证学位证书托业成绩单原版一模一样
1比1制作(swansea毕业证书)英国斯旺西大学毕业证学位证书托业成绩单原版一模一样1比1制作(swansea毕业证书)英国斯旺西大学毕业证学位证书托业成绩单原版一模一样
1比1制作(swansea毕业证书)英国斯旺西大学毕业证学位证书托业成绩单原版一模一样
 
How to Obtain Permanent Residency in the Netherlands
How to Obtain Permanent Residency in the NetherlandsHow to Obtain Permanent Residency in the Netherlands
How to Obtain Permanent Residency in the Netherlands
 
EMPLOYMENT LAW AN OVERVIEW in Malawi.pptx
EMPLOYMENT LAW  AN OVERVIEW in Malawi.pptxEMPLOYMENT LAW  AN OVERVIEW in Malawi.pptx
EMPLOYMENT LAW AN OVERVIEW in Malawi.pptx
 
Notes-on-Prescription-Obligations-and-Contracts.doc
Notes-on-Prescription-Obligations-and-Contracts.docNotes-on-Prescription-Obligations-and-Contracts.doc
Notes-on-Prescription-Obligations-and-Contracts.doc
 
WINDING UP of COMPANY, Modes of Dissolution
WINDING UP of COMPANY, Modes of DissolutionWINDING UP of COMPANY, Modes of Dissolution
WINDING UP of COMPANY, Modes of Dissolution
 
The Reserve Bank of India Act, 1934.pptx
The Reserve Bank of India Act, 1934.pptxThe Reserve Bank of India Act, 1934.pptx
The Reserve Bank of India Act, 1934.pptx
 
Daftar Rumpun, Pohon, dan Cabang Ilmu (28 Mei 2024).pdf
Daftar Rumpun, Pohon, dan Cabang Ilmu (28 Mei 2024).pdfDaftar Rumpun, Pohon, dan Cabang Ilmu (28 Mei 2024).pdf
Daftar Rumpun, Pohon, dan Cabang Ilmu (28 Mei 2024).pdf
 
Highlights_of_Bhartiya_Nyaya_Sanhita.pptx
Highlights_of_Bhartiya_Nyaya_Sanhita.pptxHighlights_of_Bhartiya_Nyaya_Sanhita.pptx
Highlights_of_Bhartiya_Nyaya_Sanhita.pptx
 
定制(nus毕业证书)新加坡国立大学毕业证学位证书实拍图原版一模一样
定制(nus毕业证书)新加坡国立大学毕业证学位证书实拍图原版一模一样定制(nus毕业证书)新加坡国立大学毕业证学位证书实拍图原版一模一样
定制(nus毕业证书)新加坡国立大学毕业证学位证书实拍图原版一模一样
 
Rokita Releases Soccer Stadium Legal Opinion
Rokita Releases Soccer Stadium Legal OpinionRokita Releases Soccer Stadium Legal Opinion
Rokita Releases Soccer Stadium Legal Opinion
 
XYZ-v.-state-of-Maharashtra-Bombay-HC-Writ-Petition-6340-2023.pdf
XYZ-v.-state-of-Maharashtra-Bombay-HC-Writ-Petition-6340-2023.pdfXYZ-v.-state-of-Maharashtra-Bombay-HC-Writ-Petition-6340-2023.pdf
XYZ-v.-state-of-Maharashtra-Bombay-HC-Writ-Petition-6340-2023.pdf
 
办理(waikato毕业证书)新西兰怀卡托大学毕业证双学位证书原版一模一样
办理(waikato毕业证书)新西兰怀卡托大学毕业证双学位证书原版一模一样办理(waikato毕业证书)新西兰怀卡托大学毕业证双学位证书原版一模一样
办理(waikato毕业证书)新西兰怀卡托大学毕业证双学位证书原版一模一样
 
Agrarian Reform Policies in the Philippines: a quiz
Agrarian Reform Policies in the Philippines: a quizAgrarian Reform Policies in the Philippines: a quiz
Agrarian Reform Policies in the Philippines: a quiz
 
ALL EYES ON RAFAH BUT WHY Explain more.pdf
ALL EYES ON RAFAH BUT WHY Explain more.pdfALL EYES ON RAFAH BUT WHY Explain more.pdf
ALL EYES ON RAFAH BUT WHY Explain more.pdf
 
Responsibilities of the office bearers while registering multi-state cooperat...
Responsibilities of the office bearers while registering multi-state cooperat...Responsibilities of the office bearers while registering multi-state cooperat...
Responsibilities of the office bearers while registering multi-state cooperat...
 
Donald_J_Trump_katigoritirio_stormi_daniels.pdf
Donald_J_Trump_katigoritirio_stormi_daniels.pdfDonald_J_Trump_katigoritirio_stormi_daniels.pdf
Donald_J_Trump_katigoritirio_stormi_daniels.pdf
 
NATURE, ORIGIN AND DEVELOPMENT OF INTERNATIONAL LAW.pptx
NATURE, ORIGIN AND DEVELOPMENT OF INTERNATIONAL LAW.pptxNATURE, ORIGIN AND DEVELOPMENT OF INTERNATIONAL LAW.pptx
NATURE, ORIGIN AND DEVELOPMENT OF INTERNATIONAL LAW.pptx
 
原版仿制(aut毕业证书)新西兰奥克兰理工大学毕业证文凭毕业证雅思成绩单原版一模一样
原版仿制(aut毕业证书)新西兰奥克兰理工大学毕业证文凭毕业证雅思成绩单原版一模一样原版仿制(aut毕业证书)新西兰奥克兰理工大学毕业证文凭毕业证雅思成绩单原版一模一样
原版仿制(aut毕业证书)新西兰奥克兰理工大学毕业证文凭毕业证雅思成绩单原版一模一样
 

mHealth Converges: The Impact of FCC, HIPAA/Privacy and FDA

  • 1. www.duanemorris.com ©2011 Duane Morris LLP. All Rights Reserved. Duane Morris is a registered service mark of Duane Morris LLP. Duane Morris – Firm and Affiliate Offices | New York | London | Singapore | Los Angeles | Chicago | Houston | Hanoi | Philadelphia | San Diego | San Francisco | Baltimore | Boston | Washington, D.C. Las Vegas | Atlanta | Miami | Pittsburgh | Newark | Boca Raton | Wilmington | Cherry Hill | Princeton | Lake Tahoe | Ho Chi Minh City | Duane Morris LLP – A Delaware limited liability partnership Ken Keane, Lisa Clark and Michael Swit mHealth Converges: The Impact of FCC, HIPAA/Privacy and FDA An Fx Conferences Audio Conference May 21, 2013
  • 2. www.duanemorris.com Standard Disclaimers • Views expressed here are solely ours and do not reflect those of our firm or any of its clients. • This presentation supports an oral briefing and should not be relied upon solely on its own to support any conclusion of law or fact. • This presentation, and the materials included herewith, are provided for general educational purposes and should not be construed as legal advice. 2
  • 3. www.duanemorris.com What We Will Cover • Background on mHealth – Lisa Clark • The FCC and mHealth – Ken Keane • FDA and mHealth – Michael Swit • Privacy and Security/HIPAA and mHealth – Lisa Clark 3
  • 5. www.duanemorris.com What is mHealth? Terms and Definitions • mHealth – is health care delivered wirelessly – facilitates health data exchange – is replacing bricks-and-mortar health care delivery • Closely related term: Health Information Technology (HIT) • Other terms: Telemedicine, Telehealth, Wireless Health, eHealth, Digital Health 5
  • 6. www.duanemorris.com mHealth Devices and Platforms • Medical devices: – Glucose meters that transmit results to electronic health record (EHR) or lab – Wearable devices to track patients who may wander • Medical apps/software – Tablet or smart phone with app that provides general medical information to physicians at bedside • Other software – Software that supports health information exchanges (HIEs) and electronic health records (EHRs) 6
  • 7. www.duanemorris.com Who uses mHealth? 1. Consumers (for themselves) - Weight apps 2. Consumers-Providers/Providers-Consumers - Glucose meters - Telepsychiatry 3. Providers-Providers - Teleradiology 4. Payors-Providers, Payors-Consumers 7
  • 8. www.duanemorris.com The mHealth Stakeholders 1. Device makers, pharma 2. Start-ups, etc. 3. Investors 4. Payors 5. Providers 6. Consumers 7. Government 8. Others: 1. Standard setting organization, academia, telecom, private organizations 8
  • 9. www.duanemorris.com Expected Growth in mHealth • Anticipated growth: – $27.3B by 2016 (BCC Research) – Growth rate at 22% through 2014 (RNCOS) • Simultaneous contraction in hospital-based and other traditional healthcare services (physician visits, etc.). 9
  • 10. www.duanemorris.com • Federal Communications Commission (FCC) • Food & Drug Administration (FDA) • Health and Human Services (HHS) – Office of the National Coordinator (ONC) – Centers for Medicare and Medicaid Services (CMS) • Federal Trade Commission (FTC) • Other – Department of Homeland Security – Department of Commerce (National Telecommunications and Information Administration) – States, etc. 10 Who is Regulating mHealth?
  • 11. www.duanemorris.com mHealth/Government Interest • Government -- actively tracking mHealth and HIT and why, where, and how to jump in. – 62 government committees (!) looking at mHealth/HIT. • Congress – three days of hearings in mid- March 2013 11
  • 12. www.duanemorris.com mHealth/Government Interest … • The Food and Drug Administration Safety Innovation Act (FDASIA) Workgroup: – “charged with providing expert input on issues and concepts identified by the Food and Drug Administration (FDA), Office of the National Coordinator for Health IT (ONC), and the Federal Communications Commission (FCC) to in order to inform the development of a report on an appropriate, risk-based regulatory framework pertaining to health information technology including mobile medical applications that promotes innovation, protects patient safety, and avoids regulatory duplication.” – First meeting was on April 29, 2013. Slides from meeting are at www.healthit.gov/sites/default/files/fdasia_kickoff_faca_slides.pdf 12
  • 13. www.duanemorris.com mHealth/This Presentation • We will review key mHealth activities regarding – FCC – FDA – Privacy and security/HIPAA • Other areas of interest include (not discussed today) – Reimbursement (Medicare, Medicaid and private) – Fraud and abuse – Licensure – Liability/insurance/malpractice – IP 13
  • 14. www.duanemorris.com The FCC and mHealth Ken Keane 14
  • 15. www.duanemorris.com FCC -- History in Wireless Medical Technology • Allocated spectrum for low-power medical telemetry 40 years ago • 460-470 MHz • Unlicensed medical applications also long allowed under FCC Rules • In 1999, established rules for implanted devices like wireless defibrillators (aka Medical Implant Communications Service or “MICS”) • 402-405 MHz15
  • 16. www.duanemorris.com FCC – History with Wireless Medical … • In 2000, designated 14 MHz for Wireless Medical Telemetry • 608-614 MHz and 1.4 GHz range • Used for telemetering patient monitoring data to central stations • In 2009, established Medical Device Radiocommunication Service (“MedRadio”) • Incorporated MICS and expanded allocation to include 401-406 MHz • Expanded rule to accommodate body-worn devices. • Rules harmonized with those in other Regions of the world16
  • 17. www.duanemorris.com FCC – History with Wireless Medical … • Applications include e.g. blood glucose monitors, and body-worn devices • In 2010, FCC signed Memorandum of Understanding with FDA. Intended to increase efficiency of regulatory processes for wireless medical devices by, e.g. • Enhancing information sharing • Coordinating approval processes 17
  • 18. www.duanemorris.com FCC – History with Wireless Medical … • In 2011, rules adopted for Medical Micropower Networks • Implanted devices surgically injected to provide artificial nervous system for stroke victims, wounded soldiers, and others with traumatic brain injuries • Spectrum allocated in response to Petition by Alfred Mann Foundation • 24 MHz in four six megahertz blocks in UHF band 18
  • 19. www.duanemorris.com MBAN Devices -- Background • In 2012, adopted rules for Medical Body Area Network Systems (“MBAN”) • Wireless devices for a wide variety of functions such as blood pressure monitoring, delivery of electrocardiogram readings, and neonatal monitoring • MBAN devices designed to be deployed widely within a hospital setting and make use of inexpensive, disposable (band-aid sized) body-worn sensors/transmitters • MBAN technology to facilitate movement of patients to different parts of the health care facility for treatment, and reduce risk of infection from wired sensors 19
  • 20. www.duanemorris.com • limitations of physical cables keep nearly half of all patients from being actively monitored. MBANs allow for ubiquitous and reliable monitoring, and give health care providers the chance to identify life-threatening problems or events before they occur • According to Institute for Healthcare Improvement, a monitored hospital patient has a 48% chance of surviving a cardiac arrest -- number drops to 6% without monitoring 20 MBAN Devices -- Background (con’t)
  • 21. www.duanemorris.com MBAN Rules • MBAN decision allocated 40 MHz of spectrum at 2360-2400 MHz for MBAN use on a secondary basis • Expansion of existing MedRadio Service in Part 95 of Rules • Permits MBAN devices to operate on a ‘license-by-rule’ basis in which users will not have to apply for and receive individual station licenses • Expected to lead to rapid and widespread development of innovative MBAN applications 21
  • 22. www.duanemorris.com MBAN Rules (con’t) • MBAN to share spectrum with primary aviation users, industry and Government. Rules contain registration and coordination provisions to protect flight test telemetry operations conducted by aerospace companies and government users. • 2360-2390 MHz long used exclusively for flight test telemetry between aircraft under test and engineers on the ground • Enables engineers to monitor performance of aircraft in real- time, and warn pilot in the event of any anomalous condition is detected • Utilizes large, dish-type tracking antennas which are very sensitive to interference 22
  • 24. www.duanemorris.com MBAN Rules (con’t) • While registration with a medical coordinator will be required, vast majority of MBAN systems in 2360- 2390 MHz will not require coordination with flight test operations due to geographic separation • Use of 2360-2390 MHz restricted to indoor operation at health care facilities at 1 mW • MBAN devices in the 2390-2400 MHz band will also share spectrum, but will not require coordination, and may be used in any location -- including in residential settings and ambulances -- and at higher power (20 mW). However, 10 MHz likely not sufficient in hospital settings. 24
  • 25. www.duanemorris.com Registration/Coordination Process: • Hospital will register with an “MBANs coordinator.” • MBANs coordinator analyzes proposal and provides data on proposed deployment to aerospace coordinator • In the great majority of cases, there will not be any interference risk, and coordination not necessary • In cases where analysis shows a risk of interference, aerospace and medical coordinators will seek to resolve situation so as to facilitate successful deployment without risk of interference to flight testing 25
  • 26. www.duanemorris.com Registration/Coordination Process (con’t) • Upon successful coordination, medical coordinator will issue hospital an “electronic key” allowing activation of MBAN systems • Beacons in hospitals ensure MBAN systems do not operate out-of-doors in 2360-2390 MHz band • In the unlikely event of interference to flight test telemetry, MBANs must immediately shut down 26
  • 27. www.duanemorris.com Registration/Coordination Process (con’t) • As part of the registration process for operating MBAN devices in the 2360-2390 MHz band, hospital will provide medical coordinator with a point of contact responsible for making changes to MBAN operating parameters (such as discontinuing operations or changing frequencies) • Most MBAN systems expected to be capable of defaulting to 2390-2400 MHz band • FCC expects its licensees to work together to resolve any instances of harmful interference 27
  • 28. www.duanemorris.com Current MBAN Status • When FCC issued decision, certain issues identified for further comment. Those issues included, in particular, selection of a medical coordinator or coordinators for MBANs. • Aerospace industry coordinator already designated, i.e. AFTRCC (association of aerospace companies)* ___________________________ * Duane Morris is counsel for AFTRCC. 28
  • 29. www.duanemorris.com Current MBAN Status (con’t) • AFTRCC, GE Healthcare, and Philips Healthcare have filed Joint Petition for Reconsideration regarding issues where the Commission departed from the proposed rules that the parties had negotiated and presented • Petition proposes a number of changes to more closely align FCC rules with IEEE standards • One issue is eligibility for 2360-2390 MHz, i.e. Commission’s decision to allow all clinics, no matter how small, to utilize MBANs devices in this band 29
  • 30. www.duanemorris.com Current MBAN Status (con’t) • Petitioners have urged that MBAN systems be limited to hospitals and other health care facilities which offer patient beds on a 24-hour basis. Small clinics, which do not need 30 MHz, could use 2390-2400 MHz • Decision probable by year end 30
  • 31. www.duanemorris.com Other FCC Activity • June 2012, FCC established mHealth Task Force • September 2012, Task Force issued Report • FCC Chairman Genachowski announced steps that FCC will take to implement key recommendations in Task Force Report including: • Streamlining experimental licensing rules to permit easier testing of mHealth devices • Reform of Rural Health Care Program to facilitate broadband connections, especially in rural areas (decision issued in December) 31
  • 32. www.duanemorris.com Other FCC Activity (con’t) • Directed FCC’s International Bureau to work with regulators in other countries to encourage making spectrum available for MBANs and to discuss spectrum harmonization • Determined to hire Health Care Director who would act as POC on all health-related issues (now on board) * * * 32
  • 34. www.duanemorris.com What is a Medical Device? • “Device” – Section 201(h) of the Federal Food, Drug, and Cosmetic Act (the Act): means: – an instrument, apparatus, implement, machine, contrivance, implant, in vitro reagent, or other similar or related article, including any component, part, or accessory, which is—  recognized in the official National Formulary, or the United States Pharmacopeia, or any supplement to them,  intended for use in the diagnosis of disease or other conditions, or in the cure, mitigation, treatment, or prevention of disease, in man or other animals, or  intended to affect the structure or any function of the body of man or other animals, and which does not achieve its primary intended purposes through chemical action within or on the body of man or other animals and which is not dependent upon being metabolized for the achievement of its primary intended purposes. 34
  • 35. www.duanemorris.com Is Software a Medical Device? • Yes, if it fits the definition of Section 201(h), where the main focus will be how the software can be used to treat, prevent or diagnose disease 35
  • 36. www.duanemorris.com FDA – Basics of Device Regulation • Devices are classified per risk – 3 Classes – Class I – least risky; typically do not require prior FDA review or approval, but must meet all other “general controls” applicable to all medical devices (e.g., facility registration, device listing, MDR reports) – Class II – more risky – typically require FDA clearance of a “Premarket Notification” Submission or “510(k)”  Standard for clearance of 510(k) – “substantial equivalence” to an already lawfully marketed device 36
  • 37. www.duanemorris.com FDA – Basics of Device Regulation – Class III – most risky – require approval of a Premarket Approval Application (PMA) –  Standard of approval – reasonable assurance of safety and effectiveness, based on clinical investigations • Classification – required of all devices on market as of May 1976; over 1,000 devices classified as to: – Identification – i.e., what is the device? – Intended use – Technological characteristics 37
  • 38. www.duanemorris.com Key to FDA Device Marketing • Must find a classification that your device meets – If not, and your device is new technology, by operation of law, your device is automatically placed in Class III • Device “classification” and mHealth Devices – – Is your product a device at all?  Even if it is, if the use is so “minor,” will FDA allow me to come to market easily?  If it is, finding a device classification that your mHealth device meets – If you can’t, what do you do about being automatically placed in Class III?38
  • 39. www.duanemorris.com FDA’s Draft Guidance on Mobile Medical Applications • July 2011 – in reply to concerns about FDA regulation of mobile apps, agency issues draft guidance – http://www.fda.gov/downloads/MedicalDevices/DeviceRegulationandGuidance/Gui danceDocuments/UCM263366.pdf – “mobile app" -- defined as a software application that can be executed (run) on a mobile platform, or a web- based software application that is tailored to a mobile platform, but is executed on a server. 39
  • 40. www.duanemorris.com FDA’s Draft Guidance on Mobile Medical Applications … – “mobile medical application” (MMA) -- mobile app that meets the definition of "device" in section 201(h) of the Federal Food, Drug, and Cosmetic Act (FD&C Act) and either:  is used as an accessory to a regulated medical device; or  transforms a mobile platform into a regulated medical device. – Intended use – is key to determining if it is a medical device; can be inferred by FDA from many sources – Others – FDA will not enforce at this time 40
  • 41. www.duanemorris.com Draft Guidance – NOT an MMA • Electronic copies of textbooks, teaching aids, or reference materials • General health & wellness apps -- solely used to log, record, track, evaluate, or make decisions or suggestions related to developing or maintaining general health and wellness – e.g. – dietary tracking logs; appointment reminders; dietary suggestions based on calorie counting • Automated office functions – e.g., billing, inventory 41
  • 42. www.duanemorris.com Draft Guidance – NOT an MMA … • Generic aids -- that assist users but are not commercially marketed for a specific medical indication. – e.g., apps that use the mobile platform as a magnifying glass (but not specifically for medical purposes), recording audio, note-taking, replaying audio with amplification, and other similar functionalities. • Mobile apps that perform the functionality of an electronic health record system or personal health record system. 42
  • 43. www.duanemorris.com Draft Guidance – Apps FDA Will Regulate • Apps that are an extension of one or more medical device(s) by connecting to such device(s) for purposes of controlling the device(s) or displaying, storing, analyzing, or transmitting patient-specific medical device data. – Examples – are considered “accessories”  remote display of data from bedside monitors  display of medical images  remote control of drug delivery of an infusion pump – Take on classification of device to which connected 43
  • 44. www.duanemorris.com Draft Guidance – Apps FDA Will Regulate … • Apps that transform the mobile platform into a medical device by using attachments, display screens, or sensors or by including functionalities similar to those of currently regulated medical devices. – Example: AliveCor™ iPhone based ECG system – physical attachment to an iPhone that converts it into an ECG and transmits data via web  510(k) cleared in November 2012 44
  • 45. www.duanemorris.com Draft Guidance – Apps FDA Will Regulate … • Apps that allow the user to input patient-specific information and - using formulae or processing algorithms - output a patient-specific result, diagnosis, or treatment recommendation to be used in clinical practice or to assist in making clinical decisions. 45
  • 46. www.duanemorris.com Why mHealth and FDA Don’t “Connect” • Lack of Transparency – – While FDA says it has reviewed and cleared/approved over 75 mHealth devices, not clear what FDA required as 2011 draft guidance is “generic” in nature  no specific guidances for clearances  difficult to find detailed info on “per device” requirements • Many mHealth Devices do not fit existing device classifications – Result – automatic Class III status under law  Challenge – de novo petition process is unwieldy 46
  • 47. www.duanemorris.com Why mHealth and FDA Don’t “Connect” • Need for more guidance – 2011 Guidance – said more guidance would be provided to cover:  Apps that use data from more than one kind of medical device  Clinical decision support software  Wireless safety considerations – for example, rumor that at least one FDAer involved in mHealth issues would require that developers prove their apps not interfere with other devices used in healthcare settings  Application of Quality System Regulation (QSR) to software 47
  • 50. www.duanemorris.com How it Came to Market • Classification – 21 CFR 870.2340 Electrocardiograph. – (a) Identification. An electrocardiograph is a device used to process the electrical signal transmitted through two or more electrocardiograph electrodes and to produce a visual display of the electrical signal produced by the heart. – (b) Classification. Class II (performance standards). • Seven consensus standards and an FDA guidance document apply – check “Product Code” to figure that out – “DPS” http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpcd/classification.cfm?ID=666 50
  • 51. www.duanemorris.com So, What Do You Do? • Meet with FDA – unless absolutely clear • Understand that you are in the medical device business and that, even if you have a Class I device, you have to meet the General Controls, which are demanding, especially: – Quality Systems Regulations  Design controls for software • Reimbursement – who will pay for it? – CMS – Private payer 51
  • 53. www.duanemorris.com Privacy and Security • The question: What are the required, recommended and best privacy and security protections for a particular mHealth product or service? – Is the product/service subject to HIPAA? – Does the FTC guidance apply? Has the FTC initiated an enforcement action against a similar product/service? – When is consent to collect/use/disclose data required? – What other federal or state laws or agencies might regulate the product/service? – What are industry best-practices? 53
  • 54. www.duanemorris.com Privacy and Security • The terms: – ‘Privacy’: protects the consumer through policies, rights to data, etc. – ‘Security’: protects the data through passwords, encryption, etc. – ‘By Design’: Designing the product/service with privacy and security in mind 54
  • 55. www.duanemorris.com Privacy and Security • The principal laws and regulations: – Health Information Portability and Accountability Act of 1996 (HIPAA) – Federal Trade Commission Act (consumer fraud, fairness) – Federal and state consent laws – Other privacy and breach laws – American Reinvestment and Recovery Act – Meaningful Use regulations 55
  • 56. www.duanemorris.com Privacy and Security • HIPAA: – Protects the privacy and security of protected health information (PHI) – Fines up to $1.5m per year for violations. – Does HIPAA apply?  Applies to Covered Entities – 1) health care providers that engage in certain electronic transactions, 2) health plans, and 3) health clearinghouses (billing companies)  Also applies to Business Associates – agents and subcontractors of Covered Entities that handle PHI, and their agents and subcontractors 56
  • 57. www.duanemorris.com Privacy and Security, HIPAA cont. • If an entity is not a Covered Entity or Business Associate, then HIPAA does not apply – a physician IS a covered entity (and so any app provided by the physician to patients, e.g., personal health record that interfaces with physician is covered) – a data management company that provides services to a hospital IS a Business Associate 57
  • 58. www.duanemorris.com Privacy and Security, HIPAA cont. • A wireless heart rate monitor service provider that permits a patient to collect heart rate data at home and send it to his/her physician • is NOT a Covered Entity if it does not bill a payor (instead bills the customer or the provider) • BUT the physician (who is a Covered Entity) must protect the PHI • Software that supports the distribution of specialized drugs to a hospital and include a patient portal provides billing services • IS a Covered Entity if it bills a payor for the hospital or individual • IS also a Business Associate because if it is billing for the hospital or performing data analysis • MAY BE a Covered Entity as a Provider 58
  • 59. www.duanemorris.com Privacy and Security, HIPAA cont. • If HIPAA applies, then must implement a Compliance Program that includes: – Privacy requirements – Notices, P&Ps, Training, Rights for Individuals, etc. – Security ‘standards’ – Access Restrictions, Audit Requirements, Disaster Recovery, etc. – Breach Notification – Breach Reporting Policy 59
  • 60. www.duanemorris.com Privacy and Security, FTC • FTC is authorized to protect the consumer against – 1) Deception (material misrepresentation, omission); – 2) Unfairness (harm or the potential for harm) • Actions: – PATH social networking app: settled with FTC for $800k against charges that it deceived users by collecting personal information from their mobile device address books without their knowledge and consent. – AcneApp: agreed to stop advertising baseless claims that app could cure acne with lights emitted from smartphones60
  • 61. www.duanemorris.com Privacy and Security, FTC Guidance • “Marketing Your Mobile App: Get It Right from the Start” business.ftc.gov/documents/bus81- marketing-your-mobile-app  Privacy by Design - Build privacy considerations in from the start.  Transparency.  Collect sensitive data with consent.  Keep data secure.  Truthful advertising, etc. - “Mobile Privacy Disclosures: Building Trust Through Transparency” www.ftc.gov/os/2013/02/130201mobileprivacyreport.pdf 61
  • 62. www.duanemorris.com Privacy and Security, FTC Guidance • “Mobile App Developers: Start with Security” business.ftc.gov/documents/bus83-mobile-app- developers-start-security – Make someone responsible. – Take stock of the data. – Understand differences between mobile platforms. – Use due diligence on third party code. – Use transit encryption for usernames, passwords, and other important data. – Protect your services, etc. 62
  • 63. www.duanemorris.com Privacy and Security, Sensitive Data and Consent • When is consent to collect/use/disclose ‘sensitive data’ required? – ‘Sensitive data’ includes: mental health, substance abuse, reproductive health, genetic, infectious disease and other data. – Different laws apply. – Consent may be obtained in writing, through opt-in/opt- out, etc. – verbal not advised. – Consent must be clear and honored. 63
  • 64. www.duanemorris.com Privacy and Security, Social Media • What is ‘social media’? – Forms of exchange of user-generated content, including blogging, chat rooms, internet forums, podcasts, instant messaging, etc. • Principle is free-flow of information (and thus difficult to control privacy and security). • No separate laws (yet). • If mHealth product/service uses social media (e.g., an app that links to a chat room), must ensure transparency of how data used, obtained consent as necessary, etc. 64
  • 65. www.duanemorris.com Privacy and Security, Other Resources • HHS’s Office of National Coordinator www.healthit.gov (authorized by ARRA to oversee development of HIT): – Development of Nationwide Privacy and Security Framework for National Health Information Exchange (HIE)  Privacy and security at every level. – Examining conflicting state laws around consent. – Developing toolkits. 65
  • 66. www.duanemorris.com Privacy and Security, Recommendations • To determine best industry privacy and security practices, work with industry groups, consultants. • General resources: – mHIMSS, www.mhimss.org – AHIMA, www.ahima.org • Obtain legal advice regarding applicable laws (HIPAA, FTC, sensitive data, breach, etc.) and whether the product/service’s privacy and security compliance program satisfies those laws. 66
  • 67. www.duanemorris.com Questions? • Ken Keane, Partner, Duane Morris – Phone: +1 202 776 5243 Email: KKeane@duanemorris.com • Lisa Clark, Partner, Duane Morris – Phone: +1 215 979 1833 Email: LWClark@duanemorris.com • Michael Swit, Special Counsel, Duane Morris – Phone: +1 619 744 2215 Email: MASwit@duanemorris.com 67